Efficacy and Long-Term Follow Up of Combination Therapy with Interferon Alpha and Ribavirin for Chronic Hepatitis C in Korea

Combination therapy with interferon alpha (IFN-α) and ribavirin for 24 or 48 weeks according to HCV genotype has improved the overall sustained virological response (SVR) rates to approximately 40%. The aim of this study was to investigate the long-term efficacy of combination therapy with IFN-α and...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kim, Jie-Hyun, Han, Kwang-Hyub, Lee, Kwan Sik, Park, Young Nyun, Ahn, Sang Hoon, Chon, Chae Yoon, Moon, Young Myoung
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Yonsei University College of Medicine 2006
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2687818/
https://ncbi.nlm.nih.gov/pubmed/17191307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2006.47.6.793
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak